GPLD1 and ovarian carcinoma: This is consistent with high activity of both biosynthetic (choline kinase) and catabolic (phosphatidylcholine-PLC/PLD) enzymes observed in ovarian carcinoma contributing to the observed choline-containing compounds accumulation in CRC tumor55.